The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling.
暂无分享,去创建一个
Maike Frye | S. Hemkemeyer | Danny Schreier | Roberta Kurelić | Christian Schulte | Manu Beerens | Viacheslav O Nikolaev | R. Mailer | T. Renné | Claudia Carlantoni | L. Liekfeld | Ceren Saygi | Roberta Kurelic | Silvia Cardarelli | Joanna Kalucka | Tilman E. Schäffer | Fabio Naro | Manuela Pellegrini | Viacheslav O. Nikolaev
[1] O. Dormond,et al. Mechanosensitive mTORC1 signaling maintains lymphatic valves , 2023, The Journal of cell biology.
[2] C. Betsholtz,et al. Claudin5 protects the peripheral endothelial barrier in an organ and vessel-type-specific manner , 2022, bioRxiv.
[3] H. Reichenspurner,et al. Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia , 2021, Redox biology.
[4] S. Stritt,et al. Homeostatic maintenance of the lymphatic vasculature. , 2021, Trends in molecular medicine.
[5] Yan Wang,et al. Biological Significance of NOTCH Signaling Strength , 2021, Frontiers in Cell and Developmental Biology.
[6] T. Renné,et al. EVL regulates VEGF receptor‐2 internalization and signaling in developmental angiogenesis , 2021, EMBO reports.
[7] B. Bardoni,et al. Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders , 2021, Molecular Psychiatry.
[8] L. Claesson‐Welsh,et al. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. , 2020, Trends in molecular medicine.
[9] S. Stritt,et al. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity , 2020, eLife.
[10] J. Kipnis,et al. The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease , 2020, Cell.
[11] Maike Frye,et al. The Importance of Mechanical Forces for in vitro Endothelial Cell Biology , 2020, Frontiers in Physiology.
[12] H. Ozaki,et al. Increased Blood Pressure Causes Lymphatic Endothelial Dysfunction via Oxidative Stress in Spontaneously Hypertensive Rats , 2020, Hypertension.
[13] A. Eichmann,et al. Lymphatic Endothelial Cell Junctions: Molecular Regulation in Physiology and Diseases , 2020, Frontiers in Physiology.
[14] A. Lenzi,et al. PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis , 2020, International journal of molecular sciences.
[15] Joshua D. Wythe,et al. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling , 2020, bioRxiv.
[16] Giovanni Parmigiani,et al. ComBat-seq: batch effect adjustment for RNA-seq count data , 2020, bioRxiv.
[17] Juan M. Vaquerizas,et al. Endothelial EphB4 maintains vascular integrity and transport function in adult heart , 2019, eLife.
[18] D. Lowy,et al. DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis , 2019, Oncogene.
[19] G. Baillie,et al. Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond , 2019, Nature Reviews Drug Discovery.
[20] Jing Wang,et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..
[21] S. Butz,et al. Distinct roles of VE‐cadherin for development and maintenance of specific lymph vessel beds , 2018, The EMBO journal.
[22] James T. Webber,et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris , 2018, Nature.
[23] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..
[24] Chuanlu Jiang,et al. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT) , 2018, BMC Neurology.
[25] Anna Szymborska,et al. Hold Me, but Not Too Tight-Endothelial Cell-Cell Junctions in Angiogenesis. , 2018, Cold Spring Harbor perspectives in biology.
[26] M. Pellegrini,et al. Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers , 2018, The Journal of cell biology.
[27] M. Komatsu,et al. Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] A. Soricelli,et al. Critical role of phosphodiesterase 2A in mouse congenital heart defects , 2018, Cardiovascular research.
[29] Liqun He,et al. Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program , 2018, Nature Communications.
[30] K. Alitalo,et al. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms , 2018, Nature Communications.
[31] K. Guan,et al. PDE2 at the crossway between cAMP and cGMP signalling in the heart. , 2017, Cellular signalling.
[32] H. Kokubo,et al. Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders. , 2017, Journal of medicinal chemistry.
[33] J. Huot,et al. The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells. , 2017, Oncotarget.
[34] M. Potente,et al. Vascular heterogeneity and specialization in development and disease , 2017, Nature Reviews Molecular Cell Biology.
[35] S. Huveneers,et al. Cell–cell junctional mechanotransduction in endothelial remodeling , 2016, Cellular and Molecular Life Sciences.
[36] P. Buijnsters,et al. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present) , 2016, Expert opinion on therapeutic patents.
[37] J. Fischer,et al. Endothelial Actions of ANP Enhance Myocardial Inflammatory Infiltration in the Early Phase After Acute Infarction. , 2016, Circulation research.
[38] M. Colonna,et al. CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability. , 2016, The Journal of clinical investigation.
[39] A. Zarbock,et al. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin , 2015, The Journal of experimental medicine.
[40] P. Scambler,et al. Increased nuchal translucency origins from abnormal lymphatic development and is independent of the presence of a cardiac defect , 2015, Prenatal diagnosis.
[41] B. Fu,et al. Reinforcing endothelial junctions prevents microvessel permeability increase and tumor cell adhesion in microvessels in vivo , 2015, Scientific Reports.
[42] Ronald N. Germain,et al. Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity , 2015, Cell.
[43] M. Delorenzi,et al. FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature. , 2015, The Journal of clinical investigation.
[44] D. Takai,et al. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer , 2015, Cancer medicine.
[45] P. Davies,et al. Lymph flow regulates collecting lymphatic vessel maturation in vivo. , 2015, The Journal of clinical investigation.
[46] M. Hill,et al. Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling. , 2015, Cardiovascular research.
[47] M. Nussenzweig,et al. Collecting Lymphatic Vessel Permeability Facilitates Adipose Tissue Inflammation and Distribution of Antigen to Lymph Node–Homing Adipose Tissue Dendritic Cells , 2015, The Journal of Immunology.
[48] Kyu-Sung Choi,et al. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2 , 2015, Nature Communications.
[49] S. Lehnart,et al. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy. , 2015, Circulation research.
[50] A. Regev,et al. Spatial reconstruction of single-cell gene expression , 2015, Nature Biotechnology.
[51] A. Hadjantonakis,et al. Murine Notch1 is required for lymphatic vascular morphogenesis during development , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.
[52] M. Sugaya,et al. Cilostazol improves lymphatic function by inducing proliferation and stabilization of lymphatic endothelial cells. , 2014, Journal of dermatological science.
[53] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[54] J. Kitajewski,et al. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium , 2013, Development.
[55] R. Weinberg,et al. The distribution of phosphodiesterase 2A in the rat brain , 2012, Neuroscience.
[56] J. Ridgway,et al. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. , 2011, Blood.
[57] Alberto Smith,et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. , 2011, The Journal of clinical investigation.
[58] K. Alitalo,et al. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. , 2011, Blood.
[59] M. Lohse,et al. FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells , 2011, Nature Protocols.
[60] J. Breslin. ROCK and cAMP promote lymphatic endothelial cell barrier integrity and modulate histamine and thrombin-induced barrier dysfunction. , 2011, Lymphatic research and biology.
[61] M. Haubitz,et al. Effect of cAMP derivates on assembly and maintenance of tight junctions in human umbilical vein endothelial cells , 2010, BMC Cell Biology.
[62] A. Engler,et al. Preparation of Hydrogel Substrates with Tunable Mechanical Properties , 2010, Current protocols in cell biology.
[63] R. Adams,et al. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. , 2009, Blood.
[64] J. Tien,et al. Effect of cyclic AMP on barrier function of human lymphatic microvascular tubes. , 2008, Microvascular research.
[65] Elisabetta Dejana,et al. Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.
[66] J. Beavo,et al. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. , 2007, Annual review of biochemistry.
[67] J. Beavo,et al. Differential Regulation of Endothelial Cell Permeability by cGMP via Phosphodiesterases 2 and 3 , 2007, Circulation research.
[68] Jiahuai Han,et al. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin αIIbβ3 , 2006 .
[69] D. Vestweber,et al. Association of Csk to VE‐cadherin and inhibition of cell proliferation , 2005, The EMBO journal.
[70] H. Barth,et al. cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. , 2004, American journal of physiology. Heart and circulatory physiology.
[71] B. Clurman,et al. Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression , 2004, Molecular and Cellular Biology.
[72] L. Favot,et al. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors , 2003, Thrombosis and Haemostasis.
[73] M. Corada,et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 , 2003, The Journal of cell biology.
[74] Taro Matsumoto,et al. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2–stimulated angiogenesis , 2002, The Journal of cell biology.
[75] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[76] Reynaldo Sequerra,et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP , 2000, Nature Genetics.
[77] R. Ye,et al. Nitric Oxide Activation of p38 Mitogen-activated Protein Kinase in 293T Fibroblasts Requires cGMP-dependent Protein Kinase* , 2000, The Journal of Biological Chemistry.
[78] M. M. Appleman,et al. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. , 1971, Biochemistry.
[79] T. Petrova,et al. Characterization of Mouse Mesenteric Lymphatic Valve Structure and Function. , 2018, Methods in molecular biology.
[80] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[81] J. Beavo,et al. Regulation of endothelial barrier function by cyclic nucleotides: the role of phosphodiesterases. , 2011, Handbook of experimental pharmacology.
[82] Manuela Zaccolo,et al. of in The Role of the in the A Molecular for Generating cAMP and cGMP Signaling Cross-Talk Role of Phosphodiesterases and Implications for Cardiac Pathophysiology , 2007 .